Roundup Settlement Calculator
Estimate a Roundup (glyphosate) NHL settlement using Bayer/Monsanto's tiered Master Settlement framework (latest tranches through 2025). Average individual settlement: $100K-$160K; trial verdicts range $5M-$2.25B (reduced). Combines exposure years, NHL subtype, severity, and economic damages.
Roundup Master Settlement Structure
Bayer/Monsanto has resolved roughly 100,000 of 165,000 Roundup NHL claims for ~$11B in total (Bayer 2024 annual report). The Master Settlement uses a points matrix: points awarded for exposure years (residential vs occupational), NHL subtype, age at diagnosis, lifestyle confounders. Average individual payout: $100K-$160K. Severe cases or strong exposure histories: $250K-$1M+. Trial verdicts (Johnson, Hardeman, Pilliod) reached $5M-$2.25B before remittitur.
NHL Subtype and Tier Assignment
Highest tier: diffuse large B-cell lymphoma (DLBCL), follicular lymphoma. Mid tier: marginal zone lymphoma, mantle cell, B-cell NHL not otherwise specified. Lower tier: chronic lymphocytic leukemia / small lymphocytic lymphoma (CLL/SLL) — Bayer disputes the link. Multiple myeloma cases were excluded from earlier settlements but new MM litigation is active. T-cell lymphoma claims are weaker (less epidemiological support).
Exposure Tiers
Tier A — occupational applicators (groundskeepers, farmers, landscapers) with 5+ years use: highest awards. Tier B — heavy residential/lawn users (1-5 acres maintained personally) 5+ years: mid. Tier C — light/occasional residential use: lowest. Documented purchase receipts, employer records, and lifetime-pesticide-use diary (EPA-style) boost the case. Confounders that reduce awards: heavy alcohol, hepatitis C, HIV, family history of NHL, organ transplant.
Statute of Limitations and Settlement Timing
Most states: 2-3 years from diagnosis date (CA = 2, NY = 3, TX = 2, FL = 4 for products liability with discovery rule). Multidistrict Litigation (MDL 2741) is still accepting cases as of 2025; new state-court filings continue. Master settlement payouts arrive in 4-12 months after enrollment. Litigation through trial takes 2-3 years.
Sources: Bayer 2024 annual report, IARC Monograph 112 (glyphosate Group 2A probable carcinogen), JNCI 2019 meta-analysis, MDL 2741 (N.D. Cal.). Last updated: May 2026. Not legal advice.
Frequently Asked Questions
What is the average Roundup settlement in 2026?
Master Settlement payouts average $100K-$160K per claim for moderate NHL cases. Severe DLBCL with strong occupational exposure: $250K-$1M+. Individual trial verdicts have reached $5M-$2.25B before reduction. Bayer has paid ~$11B across ~100,000 claims (Bayer 2024 annual report).
Which NHL types qualify for a Roundup claim?
DLBCL and follicular lymphoma are strongest (highest tier). Marginal zone, mantle cell, B-cell NHL NOS qualify but at lower tiers. CLL/SLL is disputed by Bayer. Multiple myeloma cases are a separate active litigation. T-cell lymphoma is weaker epidemiologically.
Can I still file a Roundup lawsuit?
Yes, but verify your state's product-liability statute of limitations (typically 2-4 years from diagnosis under the discovery rule). MDL 2741 in Northern District of California remains active; new state-court filings continue across the US. Contact an attorney immediately.
Are punitive damages available?
Yes — Johnson, Hardeman, and Pilliod trial verdicts included large punitive awards (later reduced under BMW v. Gore due-process limits). Master Settlement amounts include implicit punitive component. Punitive damages above the 9:1 single-digit ratio are typically reduced on appeal.
Are settlement payments taxable?
Physical-injury compensation (medical, pain & suffering tied to physical injury): non-taxable under IRC §104(a)(2). Punitive damages and lost-wages portions: taxable. Consult a tax advisor — IRS Publication 4345 covers settlement taxation.